ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.37 USD 1.48% Market Closed
Market Cap: 229.9m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

ATAI Life Sciences NV
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ATAI Life Sciences NV
Cash Equivalents Peer Comparison

Comparables:
BAYN
MRK
93M1
DMP
PSG

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Cash Equivalents
$45m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Cash Equivalents
€3.9B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
12%
Merck KGaA
XETRA:MRK
Cash Equivalents
€2.7B
CAGR 3-Years
14%
CAGR 5-Years
-5%
CAGR 10-Years
12%
MPH Health Care AG
XETRA:93M1
Cash Equivalents
€4.6m
CAGR 3-Years
131%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Cash Equivalents
€165.8m
CAGR 3-Years
18%
CAGR 5-Years
15%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ATAI Life Sciences NV's Cash Equivalents?
Cash Equivalents
45m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Cash Equivalents amounts to 45m USD.

What is ATAI Life Sciences NV's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
-23%

Over the last year, the Cash Equivalents growth was -76%. The average annual Cash Equivalents growth rates for ATAI Life Sciences NV have been -23% over the past three years .

Back to Top